全文获取类型
收费全文 | 204144篇 |
免费 | 2988篇 |
国内免费 | 158篇 |
专业分类
耳鼻咽喉 | 1379篇 |
儿科学 | 7049篇 |
妇产科学 | 3297篇 |
基础医学 | 20864篇 |
口腔科学 | 2448篇 |
临床医学 | 15085篇 |
内科学 | 37792篇 |
皮肤病学 | 1109篇 |
神经病学 | 19760篇 |
特种医学 | 10660篇 |
外国民族医学 | 1篇 |
外科学 | 32652篇 |
综合类 | 2531篇 |
一般理论 | 12篇 |
预防医学 | 19208篇 |
眼科学 | 3301篇 |
药学 | 11078篇 |
中国医学 | 678篇 |
肿瘤学 | 18386篇 |
出版年
2023年 | 249篇 |
2022年 | 353篇 |
2021年 | 823篇 |
2020年 | 510篇 |
2019年 | 720篇 |
2018年 | 22560篇 |
2017年 | 17867篇 |
2016年 | 20213篇 |
2015年 | 1865篇 |
2014年 | 2007篇 |
2013年 | 2247篇 |
2012年 | 9340篇 |
2011年 | 23296篇 |
2010年 | 20167篇 |
2009年 | 12738篇 |
2008年 | 21499篇 |
2007年 | 23664篇 |
2006年 | 2614篇 |
2005年 | 4098篇 |
2004年 | 5043篇 |
2003年 | 5889篇 |
2002年 | 3952篇 |
2001年 | 519篇 |
2000年 | 604篇 |
1999年 | 433篇 |
1998年 | 498篇 |
1997年 | 426篇 |
1996年 | 250篇 |
1995年 | 248篇 |
1994年 | 220篇 |
1993年 | 148篇 |
1992年 | 105篇 |
1991年 | 154篇 |
1990年 | 170篇 |
1989年 | 139篇 |
1988年 | 96篇 |
1987年 | 85篇 |
1986年 | 65篇 |
1985年 | 66篇 |
1984年 | 54篇 |
1983年 | 61篇 |
1982年 | 60篇 |
1980年 | 68篇 |
1974年 | 46篇 |
1938年 | 84篇 |
1937年 | 55篇 |
1935年 | 57篇 |
1934年 | 53篇 |
1932年 | 58篇 |
1930年 | 52篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Leonore Ingold Jörg Halter Maria Martinez Patrizia Amico Caroline Wehmeier Patricia Hirt-Minkowski Jürg Steiger Michael Dickenmann Stefan Schaub 《Transplant international》2021,34(10):1875-1885
The aim of this retrospective single-center study was to investigate the short- and long-term impact of neutropenia occurring within the first year after kidney transplantation, with a special emphasis on different neutropenia grades. In this unselected cohort, 225/721 patients (31%) developed 357 neutropenic episodes within the first year post-transplant. Based on the nadir neutrophil count, patients were grouped as neutropenia grade 2 (<1.5–1.0*109/l; n = 105), grade 3 (<1.0–0.5*109/l; n = 65), and grade 4 (<0.5*109/l; n = 55). Most neutropenia episodes were presumably drug-related (71%) and managed by reduction/discontinuation of potentially responsible drugs (mycophenolic acid [MPA] 51%, valganciclovir 25%, trimethoprim/sulfamethoxazole 19%). Steroids were added/increased as replacement for reduced/discontinued MPA. Granulocyte colony-stimulating factor was only used in 2/357 neutropenia episodes (0.6%). One-year incidence of (sub)clinical rejection, one-year mortality, and long-term patient and graft survival were not different among patients without neutropenia and neutropenia grade 2/3/4. However, the incidence of infections was about 3-times higher during neutropenia grade 3 and 4, but not increased during grade 2. In conclusion, neutropenia within the first year after kidney transplantation represents no increased risk for rejection and has no negative impact on long-term patient and graft survival. Adding/increasing steroids as replacement for reduced/discontinued MPA might supplement management of neutropenia. 相似文献
992.
Erzsi Tegzess Antonio W. Gomes Neto Robert A. Pol Silke E. de Boer Hessel Peters-Sengers Jan-Stephan F. Sanders Stefan P. Berger 《Transplant international》2021,34(12):2746-2754
Increasing numbers of elderly (≥65 years) patients are listed for kidney transplantation. This study compares the survival outcome between living (LDK), regularly allocated (ETKAS), and Eurotransplant Senior Program (ESP) donor kidneys in elderly recipients. This is a single-center retrospective cohort study of elderly kidney transplant recipients transplanted between 2005 and 2017. Primary outcome measures were nondeath-censored graft, death-censored graft, and patient survival. In total, 348 patients were transplanted, 109 recipients (31.3%) received an LDK, 100 (28.7%) an ETKAS, and 139 (40%) an ESP kidney. 62.5% were male, and median age was 68 years. LDK recipients had significantly better 5-year nondeath-censored graft survival compared with ETKAS and ESP (resp. 71.0% vs. 66.1% vs. 55.6%, P = 0.047). Death-censored graft survival after 1 year was significantly better in LDK recipients (99.1%) (ETKAS 90.8%; ESP 87.7%, P < 0.001). After 5 years, the difference remained significant (P < 0.001) with little additional graft loss (97.7% vs. 88.1% vs. 85.6). There was no significant difference in patient survival after 5 years (71.7% vs. 67.4% vs 61.9%, P = 0.480). In elderly recipients, the patient survival benefits of an LDK are limited, but there is decreased death-censored graft loss for LDK recipients. Nevertheless, graft survival in ETKAS and ESP remains satisfactory. 相似文献
993.
Gabriel Stefan Ana Maria Mehedinti Iuliana Andreiana Adrian Dorin Zugravu Simona Cinca Ruxandra Busuioc Ioana Miler Simona Stancu Ligia Petrescu Ioana Dimitriu Elena Moldovanu Diana Elena Crasnaru Georgeta Gugonea Valentin Georgescu Victor Dan Strambu Cristina Capusa 《Renal failure》2021,43(1):49
Background There is limited information about the clinical characteristics, treatment and outcome of maintenance hemodialysis patients with COVID-19. Moreover, regional differences are also conceivable since the extend and severity of outbreaks varied among countries.Methods In this retrospective, observational, single-center study, we analyzed the clinical course and outcomes of 37 maintenance hemodialysis patients (median age 64 years, 51% men) hospitalized with COVID-19 from 24 March to 22 May 2020 as confirmed by real-time PCR.Results The most common symptoms at admission were fatigue (51%), fever (43%), dyspnea (38%) and cough (35%). There were 59% mild/moderate patients and 41% severe/critical patients. Patients in the severe/critical group had a significantly higher atherosclerotic burden since diabetic kidney disease and vascular nephropathies were the most common primary kidney diseases and eighty percent of them had coronary heart disease. Also, Charlson comorbidity score was higher in this group. At admission chest X-ray, 46% had ground-glass abnormalities. Overall, 60% patients received hydroxychloroquine, 22% lopinavir–ritonavir, 11% tocilizumab, 24% systemic glucocorticoids, and 54% received prophylactic anticoagulation. Seven (19%) patients died during hospitalization and 30 were discharged. The main causes of death were cardiovascular (5 patients) and respiratory distress syndrome (2 patients). In Cox regression analysis, lower oxygen saturation, anemia and hypoalbuminemia at admission were associated with increased mortality.Conclusions In conclusion, we observed a high mortality rate among maintenance hemodialysis patients hospitalized for COVID-19. Anemia, lower serum albumin and lower basal oxygen saturation at admission were factors associated with poor prognosis. 相似文献
994.
Dadi Helgason Solveig Helgadottir Anders Ahlsson Jarmo Gunn Vibeke Hjortdal Emma C. Hansson Anders Jeppsson Ari Mennander Shahab Nozohoor Igor Zindovic Christian Olsson Stefan Orri Ragnarsson Martin I. Sigurdsson Arnar Geirsson Tomas Gudbjartsson 《The Annals of thoracic surgery》2021,111(4):1292-1298
995.
Max Henningsen Bernd Jaenigen Stefan Zschiedrich Przemyslaw Pisarski Gerd Walz Johanna Schneider 《Transplantation proceedings》2021,53(5):1589-1598
BackgroundLeukopenia is a common complication after kidney transplantation. The etiology is multifactorial, with medication adverse effects and cytomegalovirus infection as main causes. Optimal strategies to prevent or treat posttransplant leukopenia remain unknown. We aimed to identify risk factors for leukopenia and to investigate the benefit of switching the immunosuppressive therapy to hydrocortisone as a continuous infusion.MethodsWe retrospectively evaluated all patients with leukopenia after kidney transplantation between 2007 and 2017 at our center relative to age- and sex-matched controls.ResultsLeukopenia was associated with the degree of rejection therapy before leukopenia, the immunosuppressive therapy before transplantation, and an induction therapy with rabbit antithymocyte globulin. Patients with leukopenia exhibited increased mortality, an increased incidence of bacterial and viral infections, and more acute rejections. Switching to hydrocortisone as a continuous infusion in patients with severe leukopenia decreased the duration of leukopenia and the incidence of subsequent viral infections, especially with cytomegalovirus.ConclusionLeukopenia is a risk factor for infectious complications and mortality, and it is associated with acute rejection. Switching immunosuppressive therapy to hydrocortisone as a continuous infusion is a safe approach to reduce the duration of leukopenia and the incidence of viral infections. 相似文献
996.
997.
998.
999.